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OBJECTIVES To test our hypothesis that the development of vulnerable plaques is not limited to the culprit
lesions, but is a pan-coronary process, we directly observed all three major coronary arteries
by angioscopy and evaluated the prevalence of yellow plaques in patients with myocardial
infarction (MI).
BACKGROUND Although pathologic studies have suggested that the disruption of atheromatous plaque plays
a major role in the development of acute MI, the prevalence of yellow plaques in the whole
coronary arteries of patients with MI has not been clarified.
METHODS Thirty-two patients undergoing follow-up catheterization one month after the onset of MI
were prospectively and consecutively enrolled in this study. The prevalence of yellow plaques
and thrombus in the major coronary arteries was successfully evaluated in 20 patients (58
coronary arteries, 21 culprit lesions) by coronary angioscopy. The diameter stenosis (DS) of
the culprit lesions and the maximal diameter stenosis (maxDS) of nonculprit segments were
angiographically measured for each coronary artery.
RESULTS The DS of the culprit lesions and maxDS were 27 6 17% and 19 6 13%, respectively. Yellow
plaques and thrombus were detected in 19 (90%) and 17 (81%) of 21 culprit lesions,
respectively. Yellow plaques were equally prevalent in the infarct-related and non–infarct-
related coronary arteries (3.7 6 1.6 vs. 3.4 6 1.8 plaques/artery). However, thrombus was
only detected in the nonculprit segments of one (2%) coronary artery.
CONCLUSIONS In patients with MI, all three major coronary arteries are widely diseased and have multiple
yellow though nondisrupted plaques. Acute MI may represent the pan-coronary process of
vulnerable plaque development. (J Am Coll Cardiol 2001;37:1284–8) © 2001 by the
American College of Cardiology
Pathologic and angioscopic studies (1–8) have revealed that
thrombus covers the disrupted intracoronary atheromatous
plaques in patients with acute myocardial infarction (MI)
and have suggested that disruption of the plaques may play
a major role in the development of acute MI. However, the
prevalence of atheromatous plaques in the nonculprit seg-
ments of the infarct-related coronary arteries and in the
noninfarct-related coronary arteries of patients with acute
MI has not been clarified. Goldstein et al. (9) demonstrated,
using coronary angiography, the existence of additional
unstable lesions other than the culprit lesions in 21% of
patients with MI; these lesions were defined as total or
subtotal occlusion with evidence of thrombus or as stenosis
with clear ulceration, fissuring and/or intraluminal filling
defects. They suggested that plaque instability may not
represent a mere random “vascular accident,” but may
perhaps reflect a “pan-coronary” process. However, acute
MI is frequently caused by angiographically normal to
mildly stenotic lesions (10) that cannot be identified by
coronary angiography as the vulnerable lesions. Angioscopy
may be more useful than angiography to detect vulnerable
plaques, because vulnerable plaques are easily detected as
yellow plaques (4–8,11,12). We hypothesized that MI
occurs accidentally at one of the multiple vulnerable plaques
prevalent throughout the coronary arteries. To test this
hypothesis, we evaluated, using coronary angioscopy, the
prevalence of yellow plaques in all three major coronary
arteries in patients with MI.
METHODS
Study patients and protocol. From September 1997 to
August 1998, we prospectively and consecutively enrolled
32 patients undergoing follow-up catheterization one
month after the onset of MI. Angioscopic studies of all
three major coronary arteries were performed to evaluate the
prevalence of yellow plaques and thrombus. Myocardial
infarction was confirmed by creatine kinase-MB fraction
elevation and demonstration of coronary artery occlusion in
the acute phase by angiography. In all patients, reperfusion
therapy was successfully performed by balloon angioplasty
with or without stenting or thrombolysis. Informed, written
consent was obtained from all patients. The patients’ char-
acteristics were also collected. This study protocol was
approved by the Osaka Police Hospital Ethical Committee.
Twelve patients were excluded from analysis because two
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or more coronary arteries were not successfully observed by
angioscopy due to arterial tortuosity or stenosis. Therefore,
20 patients (15 men and 5 women, age 59 6 10 years) were
included in the present study. In 2 of 20 patients, the right
coronary artery (RCA) was not successfully observed. In one
patient, inferior acute MI occurred during follow-up of
anterior MI, and two lesions in the left anterior descending
coronary artery (LAD) and RCA were regarded as culprit
lesions. Therefore, 58 coronary arteries, including 21 culprit
lesions, were analyzed in those 20 patients. Stenting and
thrombolysis were performed in two patients and one
patient, respectively. Table 1 describes the characteristics of
the study patients. A representative case is shown in Fig. 1.
Angiographic analysis. Catheterization was performed by
the femoral artery approach using an 8F sheath and cathe-
ters. The coronary angiogram was recorded with the Ad-
vantx Medical System (General Electric, Milwaukee, Wis-
consin). The left coronary arteries were evaluated from at
least four views, and the RCAs from at least two views. The
diameter stenosis (DS) of the culprit lesions and the
maximal diameter stenosis (maxDS) of each coronary artery,
excluding the culprit lesion, were determined by quantita-
tive coronary angiography. The vessel contour (smooth,
irregular, ulcerative or hazy) was also evaluated. On the
angiogram, thrombus was defined as the filling defect of
mobile fragments or haziness, although the filling defect of
the mobile fragments is usually detected in the acute stage of
acute coronary syndromes (ACS), and only haziness was
actually detected in the present study.
Angioscopic procedures and evaluations. We used the
angioscope MC-800E (Nihon Kohden, Tokyo, Japan) and
the optic fiber AS-003 (Nihon Kohden). The angioscopic
observations were made while the blood was cleared away
from the view by the injection of 3% dextran-40, as
described previously (7). We continuously examined the
whole coronary artery from the distal segment to the ostium
of all three major coronary arteries if the lumen diameter
was $2 mm, and we evaluated the existence of yellow
plaques and thrombus. There was no complication associ-
ated with the angioscopic procedures. Yellow plaque was
simply defined as the yellow area on the lumen surface,
which may have a smooth or irregular surface with or
without protrusion into the lumen. Thrombus was defined
as white or red material that has a cotton-like or ragged
appearance or fragmentation, which may be protruding into
the lumen or adhering to the lumen’s surface. The preva-
lence of yellow plaques and thrombus was determined for
the culprit and nonculprit segments separately, and the
number of yellow plaques in each coronary artery, excluding
or including the culprit lesions, was counted. Evaluations of
the angioscopic images were performed by two angioscopy
specialists who had no knowledge of the clinical data, and in
case of disagreement, the third reviewer decided the inter-
pretation. The interobserver and intraobserver reproducibil-
ities for interpretation of the angioscopic images were 96%
and 100% for plaque color and 94% and 91% for thrombus,
respectively.
Determinants for the number of yellow plaques. The
number of yellow plaques in a coronary artery was compared
between: 1) infarct-related and noninfarct-related coronary
arteries; 2) men and women; 3) LAD and left circumflex
Abbreviations and Acronyms
ACS 5 acute coronary syndrome
DS 5 diameter stenosis
HDL 5 high density lipopotein
IVUS 5 intravascular ultrasound
LAD 5 left anterior descending coronary artery
maxDS 5 maximal diameter stenosis
MI 5 myocardial infarction
RCA 5 right coronary artery
Table 1. Patients’ Characteristics (n 5 20)
Angioscopic observations (n)
Coronary arteries 58
LAD 20
LCx 20
RCA 18
Culprit lesions 21
LAD 10
LCx 5
RCA 6
Male 75%
Age (yrs) 59 6 10
Hypertension 62%
Diabetes mellitus 36%
Hyperlipidemia 60%
Smoker 56%
Total cholesterol (mg/dl) 216 6 35
HDL cholesterol (mg/dl) 46 6 10
Triglyceride (mg/dl) 169 6 122
Data are presented as the number of patients, percentage of patients or mean value
6 SD.
HDL 5 high density lipoprotein; LAD 5 left anterior descending coronary artery;
LCx 5 left circumflex coronary artery; RCA 5 right coronary artery.
Figure 1. A representative patient (58-year-old man) with anterior myo-
cardial infarction. Angioscopic images of the culprit lesion (nos. 8 and 9)
and of all the yellow plaques in the nonculprit segments are presented.
Thrombus was detected over the yellow plaque in the culprit segment.
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coronary artery and RCA; and 4) patients with and those
without hypertension, hypercholesterolemia, diabetes mel-
litus or a smoking habit. The relationship between the
number of yellow plaques and the patient’s age or serum
levels of total cholesterol, high density lipoprotein (HDL)
cholesterol or triglycerides was also evaluated.
Coronary events. The data on cardiac events (death, ACS,
coronary artery bypass graft surgery or percutaneous trans-
luminal coronary angioplasty) were collected from the clin-
ical records after the angioscopic study, by the end of
September 2000. The follow-up period was 931 6 107 days.
Statistical analysis. All data were presented as the mean
value 6 SD. The number of yellow plaques in an infarct-
related coronary artery and a noninfarct-related coronary
artery was determined separately for each patient by calcu-
lating the average if there were two or more infarct-related
or noninfarct-related coronary arteries, and the difference
between the infarct-related and noninfarct-related coronary
arteries was analyzed by the paired t test. The difference in
the number of yellow plaques between three coronary vessels
was analyzed by the paired t test. The average number of
yellow plaques in a coronary artery was determined for each
patient by calculating the average of all major coronary
arteries, and the difference of this average number of yellow
plaques between the groups, defined by various risk factors
(hypertension, hypercholesterolemia, diabetes mellitus and
smoking) or gender, was analyzed by using the unpaired t
test. The correlation between the number of yellow plaques
and the patient’s age or serum levels of total cholesterol,
HDL cholesterol or triglycerides was assessed by linear
regression analysis using the least squares method. The
value p , 0.05 was regarded as significant.
RESULTS
Culprit lesions of MI. The DS of the culprit lesions was
27 6 17% (range 0% to 55%). On the angioscopic images,
we observed yellow plaques and thrombus in 19 (90%) and
17 (81%) culprit lesions, respectively. Slight haziness was
detected by angiography in 4 (19%) culprit lesions, and
thrombus was angioscopically detected in all of them.
However, thrombus was also detected by angioscopy in 13
culprit lesions (62%) with a smooth contour on the angio-
gram. Therefore, angiography could detect thrombus in
only 24% of the culprit lesions in which thrombus was
detected by angioscopy. Yellow plaques were found in 6
culprit lesions (29%) with mild stenosis on the angiogram;
irregular or ulcerative contour was found in 9 culprit lesions
(43%) with mild stenosis and smooth contour and in 4
culprit lesions (19%) without stenosis and with smooth
contour. Both stented culprit lesions, where angiography
revealed no stenosis, irregularity or haziness, had yellow
plaque and thrombus.
Distribution of yellow plaques in the whole coronary
arteries. The maxDS of the nonculprit segments was 19 6
18% (range 0% to 65%). Twenty-three coronary arteries
(40%) did not have either lumen stenosis or vascular wall
irregularity by coronary angiography. In the nonculprit
segments of all patients, 17 mildly stenotic lesions (one with
hazy contour and 16 with smooth contour) were detected by
angiography, and 185 yellow plaques were detected by
angioscopy. Although 16 (94%) of those 17 lesions had
yellow plaque, 169 (91%) of 185 yellow plaques were found
in the site where angiography was completely normal. Even
after knowing the existence of yellow plaque, no specific
angiographic sign was detected for them. Yellow plaques
were observed in the nonculprit segments in 55 (95%) of 58
coronary arteries. Thrombus was detected in the nonculprit
segment only in 1 coronary artery (2%) in the segment of
angiographic haziness with mild stenosis where yellow
plaque was also detected.
The mean number of yellow plaques detected in a
coronary artery, excluding the culprit lesion, was 3.2 6 1.7
(the distribution is presented in Fig. 2). Yellow plaques were
equally prevalent in the infarct-related and non–infarct-
related coronary arteries (3.7 6 1.6 vs. 3.4 6 1.8 plaques/
artery, including the culprit lesion; p 5 NS). Significantly
more yellow plaques were detected in the right as compared
with the left circumflex coronary artery or LAD (4.4 6 2.1
vs. 2.8 6 1.3 or 3.5 6 1.5 plaques/artery, including the
culprit lesion; p , 0.05). However, the number of yellow
plaques had no significant relationship with the rest of the
factors (age, gender, hypertension, hypercholesterolemia,
diabetes mellitus, smoking or serum levels of total choles-
terol, HDL cholesterol or triglycerides).
Coronary events. No death or bypass surgery was observed
among the enrolled patients. Acute MI was observed in one
patient; however, because the culprit lesion was in the distal
segment of the RCA, it had not been observed by angios-
copy, and whether the MI occurred at the yellow plaque was
not determined. Percutaneous transluminal coronary angio-
plasty was performed in four patients because of restenosis
of the culprit lesion (three of them had yellow plaque).
Figure 2. Number of yellow plaques observed in the nonculprit segments.
The distribution of the number of yellow plaques observed in a coronary
artery is presented. The mean (6 SD) number of the yellow plaques is
3.2 6 1.7.
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DISCUSSION
Our previous report demonstrated that the yellow plaques
were detected in the culprit lesions in 93% of patients with
acute MI and suggested that yellow plaques play a major
role in the development of MI. However, so far, no reports
have evaluated the prevalence of yellow plaques in the whole
coronary arteries, especially in the nonculprit segments. In
the present study, on the angioscopic images, we observed
all three major coronary arteries in patients with MI,
revealing that yellow plaques exist not only in the culprit
lesions but also in the nonculprit segments, both in the
infarct-related and noninfarct-related coronary arteries.
This finding clarified that all three major coronary arteries
are similarly diseased and have multiple yellow plaques in
patients with MI.
Vulnerability of yellow plaques. Thieme et al. (12) vali-
dated angioscopic observations with histologic assessment
of the material removed by coronary atherectomy, and they
suggested that the yellow plaque color is closely related to
degenerated plaque or atheroma and is associated with
ACS. Waxman et al. (13) demonstrated that yellow plaques
are associated with the risk of adverse outcomes after
balloon angioplasty, and they suggested that yellow plaques
may have an increased thrombogenic potential. We previ-
ously reported that yellow plaques were observed in only
64% of patients with stable angina who had no history of
MI, but in 93% of patients with acute MI and in 95% of
patients with unstable angina. Thieme et al. (12) also
demonstrated that yellow plaques were detected in only 57%
of patients with stable angina, but in 89% of patients with
unstable angina. These results support the idea that the
presence of yellow plaques is closely associated with the
vulnerability of the lesions and unstable symptoms, and that
yellow plaques likely cause ACS, although the natural
course of yellow plaque development and disruption has not
been established. On the basis of these reports, the present
study suggests that whole major coronary arteries in patients
with MI are extensively diseased and have multiple vulner-
able plaques that have a possibility to cause another ACS,
although it is not clear how great this possibility is.
It has been demonstrated that cholesterol-lowering ther-
apy with hydroxymethyl glutaryl coenzyme A reductase
(14,15) reduces the incidence of acute MI, and that it is
more effective in patients with a previous MI than in those
without it. This, combined with our results, suggests that
patients with a previous MI had more vulnerable plaques in
need of stabilization by this therapy, and that cholesterol-
lowering therapy may change the appearance of the yellow
plaques and stabilize its vulnerability.
Although no event of ACS was observed to result from
the yellow plaques during ;2.5 years of follow-up among
the enrolled patients, intensive treatment with beta-
blockers, antiplatelets and lipid-lowering therapy might
have prevented the occurrence of ACS. To evaluate the
vulnerability of yellow plaques, patients who are not inten-
sively treated or a larger number of patients should be
studied.
Development of yellow plaques as a pan-coronary pro-
cess. Goldstein et al. (9) revealed, by using coronary an-
giography, the existence of additional unstable lesions other
than the culprit lesions in 21% of patients with MI, and
suggested that plaque instability may not represent a mere
random “vascular accident,” but perhaps may reflect a
“pan-coronary” process. Their suggestion was supported and
further confirmed by our finding that additional vulnerable
plaques exist extensively throughout the whole major coro-
nary arteries in patients with MI. The difference in the
prevalence of unstable plaques between their study (9) and
ours may be due to the difference in the modality used to
detect the plaques.
Detection of vulnerable plaques by angioscopy. The
sensitivity of angioscopy to detect vulnerable plaques may be
high because: 1) the culprit lesions of ACS appear to be
predominantly yellow; 2) thrombus is five times more likely
to be found in association with yellow as compared with
white lesions (16); 3) angioscopically demonstrated yellow
plaque has been shown to have a large lipid core and a thin
fibrous cap and has been associated with unstable clinical
situations; and 4) it is extremely easy to find the yellow
lesions on the white lumen surface, However, there is little
information on its specificity. However, because all yellow
plaques may not be vulnerable, further research is required
to find out the characteristics of the highly vulnerable
plaques among the yellow plaques. The culprit plaques of
ACS (7,17) have a similar appearance of: 1) vividly yellow
color that is sometimes glistening; 2) an irregular surface,
sometimes with the protrusion of the plaque content; 3)
adherence of the predominantly white thrombus, revealing a
ragged or cotton-like appearance; and 4) intramural hem-
orrhage manifested as a blood-red discoloration of the
lumen’s surface. Glistening yellow color (18) has been
reported to be predictive of ACS, and the existence of
thrombus is known to be a risk factor of adverse cardiac
events. However, some of the characteristic appearances
observed in the culprit lesions of ACS may be acquired by
the disruption of the plaque, and the appearance of vulner-
able plaques before imminent disruption may be different.
To test whether various angioscopic findings can be a sign of
vulnerability in the plaques before disruption, prospective
clinical trials may be required.
Although some of the angioscopic findings may be a sign
of vulnerability, intravascular ultrasound (IVUS) imaging
may also be useful to identify the highly vulnerable plaques
among the yellow plaques, because IVUS gives us additional
information on the sectional images of the plaques. Com-
pensatory enlargement of the arterial segments, as (19)
detected by IVUS, has been associated with angioscopically
demonstrated unstable lesions. Further detailed sectional
images obtained by optical coherence tomography (20) may
also be useful to identify the specifically vulnerable plaques.
The combination of these modalities may increase the
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specificity of the angioscopic study to identify the highly
vulnerable plaques, and may be able to identify patients who
have a high risk of developing acute MI in the early stage of
plaque formation, when angiography cannot detect any
abnormal sign.
Study limitations. This study has two limitations: the
study group was small and the small vessels (diameter
,2 mm) were not included. The prevalence of yellow
plaques in patients with stable effort angina or in patients
without coronary artery disease remains to be established,
because we observed the coronary arteries only in patients
with MI. The prevalence of yellow plaque or thrombus at
the culprit lesions may possibly differ after different reper-
fusion therapy. However, plaque color is not likely to be
altered by stents that are usually not covered by the
neointima as long as 45 days after implantation (21).
Conclusions. Whole coronary arteries are diseased and
have multiple yellow plaques in patients with MI, and the
development of MI may reflect the pan-coronary process of
vulnerable plaque formation. Therefore, once the patients
present with acute MI, they must have additional vulnerable
plaques, which possibly cause another ACS, so they should
be treated intensively to prevent the next coronary event.
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